Skip to content
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
TrueView 100 Pro
Navigator System
Navigator System
Navigator Sterilization
MarginProbe
MarginProbe
Breast Cancer
Partial Mastectomy
Lumpectomy Surgery
Ductal Carcinoma in Situ (DCIS)
Lumpectomy Margins
Patients
MarginProbe Advantage
Physicians
Clinical Data
Hemoblast
Clinical Data
Economic Value
Surgical Videos
CoPilot VL
About
Careers
News
Contact
Contact
Intraoperative Tissue Characterization Probe as a Potential Tool for Surgical Margin Assessment.
June 6, 2005
/
Clinical Data
[vc_row][vc_column][vc_column_text]
View Study
[/vc_column_text][/vc_column][/vc_row]
Posted in
Clinical Data
Posts navigation
← Twenty-Year Follow-Up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy Plus Irradiation for the Treatment of Invasive Breast Cancer
Intraoperative Tissue Characterization Probe as a Potential Tool for Surgical Margin Assessment →